CBT for Syndemics and Adherence Factors for Adherence, Medication

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Miami, Miami, FL
Adherence, Medication+1 More
CBT for Syndemics and Adherence Factors - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this study is to learn about ways to better support people living with HIV with their HIV treatment and cope with mental health challenges and/or substance use concerns.

Eligible Conditions

  • Adherence, Medication
  • Mental Health Issue

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Adherence, Medication

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: 8 months

8 months
Percentage of participants who completes the follow up assessment
Up to 8 months
ART Medication Adherence
Percentage of participants with improvement in syndemic, behavioral health outcomes
Percentage of participants with undetectable viral load

Trial Safety

Safety Progress

1 of 3

Other trials for Adherence, Medication

Trial Design

1 Treatment Group

Cognitive Behavioral Therapy (CBT) for Syndemic and Adherence Factors Group
1 of 1
Experimental Treatment

75 Total Participants · 1 Treatment Group

Primary Treatment: CBT for Syndemics and Adherence Factors · No Placebo Group · N/A

Cognitive Behavioral Therapy (CBT) for Syndemic and Adherence Factors Group
Behavioral
Experimental Group · 1 Intervention: CBT for Syndemics and Adherence Factors · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 8 months

Trial Background

Prof. Steven Safren, Professor
Principal Investigator
University of Miami
Closest Location: University of Miami · Miami, FL
Photo of University of Miami  1Photo of University of Miami  2Photo of University of Miami  3
1991First Recorded Clinical Trial
5 TrialsResearching Adherence, Medication
619 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You must be younger than age 18 years.
You have evidence of uncontrolled virus (e.g.
You are HIV positive.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.